Branded as the diabetes capital of the world, India today got itself a national programme for control of non-communicable diseases at a cost of Rs 1230.9 crore.
Branded as the diabetes capital of the world, India today got itself a national programme for control of non-communicable diseases at a cost of Rs 1230.9 crore.
The National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS)
was approved by the cabinet committee on economic affairs.
The CCEA sanctioned Rs 1230.90 crore for implementation of its various components during the remaining period of 11th Five year plan. Out of this, Rs 499.38 crore would be for interventions on diabetes and cardiovascular diseases and stroke and Rs 731.52 crore for cancer control.
The cost sharing between the Centre and the states would be 80:20, Union Home Minister P Chidambaram told reporters here.
The CCEA also approved the inter-usability of funds from one component to another within the same group of diseases,
limited to a ceiling of 10 per cent, in order to impart
operational flexibility in implementation of these programmes.
Approval has also been accorded for empowering the Mission Steering Group and Empowered Programme Committee set
up under the National Rural Health Mission (NRHM) to approve
financial norms in respect of all components of the Programme.
The programme will be implemented in 20,000 sub-centres and 700 Community Health Centres (CHCs) in 100 Districts across 15 States/UTs by promoting healthy lifestyle through massive health education and mass media efforts at country level, opportunistic screening of persons above the age of 30 years and establishment of Non Communicable Disease (NCD) clinics at CHC and district level.
It is expected to screen over seven crore adult population (30 years and above) for diabetes and hypertension, early diagnosis of NCDs and treatment at early stages.
To fill the gap in the health delivery system, about 32,000 health personnel would be trained at various levels to provide opportunistic and targeted screening, diagnosis and management of NCDs.
The country is experiencing a rapid health transition with a rising burden of Non-Communicable Diseases(NCDs) which are emerging as the leading cause of death in India accounting
for over 42 per cent of all deaths with considerable loss in
potentially productive years (aged 35-64 years) of life.
According to a WHO report (2002), cardiovascular diseases
(CVDs) will be the largest cause of death and disability in
India by 2020.
It is estimated that the overall prevalence of diabetes, hypertension, Ischemic Heart Diseases (IHD) and stroke is
62.47, 159.46, 37.00 and 1.54 respectively per 1000 population
of India.
There are an estimated 25,00,000 cancer cases in India.
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
)
){kind=small}
){kind=small}
)
)
)
)
)
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}